Importance of Device Evaluation for Point-of-Care Prothrombin Time International Normalized Ratio Testing Programs
- 28 February 2005
- journal article
- clinical trial
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 80 (2), 181-186
- https://doi.org/10.4065/80.2.181
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2003
- Reliability of international normalised ratios from two point of care test systems: comparison with conventional methodsBMJ, 2003
- Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2003
- Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testingBritish Journal of Haematology, 2002
- Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart ValvesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- Point-of-care versus laboratory measurement of the International Normalized RatioAmerican Journal of Health-System Pharmacy, 2000
- Genetic control of anticoagulationThe Lancet, 1999
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996